News Focus
News Focus
Followers 11
Posts 586
Boards Moderated 0
Alias Born 12/19/2019

Re: rafunrafun post# 341156

Friday, 05/28/2021 10:26:36 AM

Friday, May 28, 2021 10:26:36 AM

Post# of 447931
The only positive that these numbers show is that the often denigrated (albeit unfairly) Amarin sales effort is actually quite effective and is doing a good job. The market is being cultivated, educated and grown completely at the expense of a tiny company in Bridgewater New Jersey. Looks like this "winning strategy" is being doubled down on by leadership and will continue to provide great sources of "hey mom, look what I got" revenue for the generics for years to come. Time to face simple realities. The legal system gets us nowhere. The trial will go forward. The Judge is not a pushover that is somehow unable to see the clear points that were made two days ago- but be careful what you wish for. The district court and the appeal process will take every bit of 5 years or more with outcomes uncertain until the very end. The generics are not fearful in anyway of treble damages- they know this is a farce based on the actions in Nevada and then the CAFC. The supply issues are temporary. Profit is the great motivator that will take care of supply chain inadequacies in short order. The quality of the encapsulation method will not be much of an issue as oxidation is a concern for thousand of products that are encapsulated.

Time to reduce the US footprint ASAP! Amarin needs a generic offering and all eyes should be focused on Europe.

Just had to rant! I did make my first buy since early last year yesterday.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News